Suchi Saria demonstrates a new AI system developed at Johns Hopkins University that speeds sepsis detection to prevent deaths Credit: Will Kirk/ Johns Hopkins University
A new study found that tuberculosis is a major cause of deadly sepsis among people living with HIV, particularly in Africa. Early treatment of TB has been shown to significantly reduce sepsis deaths, with a 23% reduction in mortality rate.
A retrospective analysis of pediatric sepsis deaths found Black children were 2.5 times more likely to die from sepsis, with an overall mortality rate of 1.65% compared to 1.27% for white children. The study highlights the need to identify factors contributing to racial disparities in sepsis outcomes.
A pioneering study has identified interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups. IL-6 outperformed traditional biomarkers in distinguishing bacterial from non-bacterial infections and stratifying sepsis severity.
A new study found that only one out of four recommended screening tools for sepsis is reliable, with NEWS-2 accurately predicting 72.2% of all sepsis cases. The study also highlights the need for better awareness and more frequent use of effective screening tools to improve early sepsis recognition and survival rates.
The new center aims to advance understanding, prevention, and management of sepsis through innovative research. Dr. Chanu Rhee and Dr. Michael Klompas will lead the effort, building on their expertise in sepsis surveillance, prevention, treatment, and policy.
Researchers have mapped how the immune response in people with sepsis changes over time, revealing three distinct immune states. This finding could lead to targeted treatments for sepsis patients, as the immune state doesn't match the clinical stage of sepsis.